CA
NZ
UK
AU
IND
US
● No clinical-trial result, regulatory decision, financing disclosure,Partnershipannouncement or analyst rating change could be reliably dated to the session.
● Voyager Therapeutics closed at $2.45 on Friday, October 2, 2026, a decline of 8.41% on the session.
● No press release, regulatory update, clinical disclosure or corporate announcement tied to the session could be confirmed from available sources.
● No clinical-trial result, regulatory decision, financing or analyst action could be tied to the session to explain the move.
● No clinical readout, regulatory decision, partnership, financing orEarningsevent was identified for October 2 to account for the gain.
● NoEarningsrelease, test launch, reimbursement decision or analyst action could be tied to the session.
● No clinical-trial result, regulatory decision, licensing orPartnershipannouncement, management change or analyst action could be dated to the session.
● Anbio Biotechnology closed at $5.55 on Friday, October 2, 2026, a decline of 11.77% on the session.
● No clinical-trial readout, regulatory decision, financing orPartnershipannouncement, management change or analyst action could be dated to the session.
● No company-specific announcement was found for OKYO Pharma, and the advance reflects speculative biotech and low-float momentum.
Please wait processing your request...